Emerging biotechnology company advancing multi-pMHC targeted T cell engagers to address tumor heterogeneity and resistance Differentiated approach integrates proprietary T cell receptor (TCR)...

Six abstracts, including one oral presentation, underscore Jazz's ongoing commitment to generating real- world evidence addressing rare neurological disorders, including rare and severe forms of...

In the news release, The Dogist Named Closing Keynote Speaker for NAPHIA Engage 2026, issued 08-Apr-2026 by NAPHIA over PR Newswire, we are advised by the company that changes have been made. The...

The RadPro Dev Kit enables Defense Industrial Base (DIB) evaluation of QuickLogic's U.S. fabricated Radiation Hardened RadPro FPGA Demonstration will include the Aurora FPGA User Tools for...

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following...